Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study
Anne R. Schlösser(Erasmus MC), DirkJan Hijnen, Sara J. Baart(Erasmus MC), Anouk G. M. Caron(GGD Amsterdam), Phyllis I. Spuls, Renske Schappin(University Medical Center Utrecht), Tamar Nijsten(Erasmus MC), Merle S. Den Ouden(Erasmus MC), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam)
Cited by 3
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
|Journal of Clinical Oncology|2015|619
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
Absence of T-regulatory cell expression and function in atopic dermatitis skin
|Journal of Allergy and Clinical Immunology|2005|272